Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Felice Gavosto"'
Autor:
Felice Gavosto
Publikováno v:
Haematologica, Vol 103, Iss 2 (2018)
Externí odkaz:
https://doaj.org/article/48d55b61255b452d8a0d04365d39a936
Publikováno v:
Leukemialymphoma. 1(2)
A complete and persistent clinico-hematologic remission was obtained in an M4 acute myeloid leukemia patient after treatment with recombinant interleukin 2 (rIL2) alone. After two autologous bone-marrow transplantations and in the third relapse with
Autor:
Anna Novarino, Giovanna Meloni, Silvia Tosti, Robert Foa, Felice Gavosto, Franco Mandelli, Susanna Fenu
Publikováno v:
British Journal of Haematology. 77:491-496
Summary. Twelve patients with acute myeloid leukaemia (AML) with evidence of resistant disease were treated with recombinant interleukin 2 (rIL2) given intravenously by continuous infusion. No objective response to rIL2 alone was documented in the se
Publikováno v:
British Journal of Haematology. 48:167-169
Semisolid agar cultures of committed granulocyte monocyte precursors (CFU-GM) make it possible to study the regulation of normal and abnormal stem cells. In vitro growth of CFU-GM is dependent on the presence of specific stimulators, called CSA (colo
Autor:
Fiorella Sanavio, Felice Gavosto, A. Severino, C. Volta, Wanda Piacibello, A. Monteverde, Massimo Aglietta, Alessandra Stacchini, S. Morelli, L Fubini, P. Pasquino
Publikováno v:
STEM CELLS. 11:83-87
Granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin 3 (IL-3) target cells have been studied in vivo in subjects with normal hemopoiesis. GM-CSF administration elicits a rapid and sustained neutrophilia, monocytosis and eosinophi
Autor:
Franco Mandelli, R. Talamint, Robert Foa, M. Giudici, G. Rezza, G. Saliva, S. Monfardini, Mario Clerici, Antonietta Cargnel, Filippo Gherlinzoni, A. Vaglia, Vincenzo Montesarchio, Francesco Puppo, A. Scanni, E. Raise, Felice Gavosto, Emanuela Vaccher, P. L. Garavelli, Edoardo Rossi, Marco Rizzi, S. Marigo, F. Fiaccadori, De Lalla, P. Dessalvi, A. Malfitano, Adriano Lazzarin, G. Lambertenghi Deliliers, N. Moroni, T Barbui, Giuseppe Luzi, Carlo Bernasconi, Umberto Tirelli, Domenico Errante, A. Cajozzo, Roberto Luzzati, Alessandro Sinicco, Giuliano Rizzardini, F. Albericci
Publikováno v:
Leukemia & Lymphoma. 3:375-384
Fifty cases of Hodgkin's disease in intravenous drug users (IVDU) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (G.I.C.A.T.). Ninety-two per cent of the patients were males; the median age was 26 years. Persistent genera
Autor:
Felice Gavosto, C. Rosso, Angela Tassinari, Alfonso Zaccaria, Giuseppe Saglio, Anna Serra, Angelo Guerrasio, Umberto Mazza, Giovanna Rege-Cambrin
Publikováno v:
Blood. 76:1819-1824
A new and rare type of Bcr/Abl junction between exon C3 of the 3′ portion of the Bcr gene and Abl exon 2 has been identified in the leukemic cells of two Ph1-positive chronic myelogenous leukemia patients in chronic phase. This is the fourth type o
Autor:
Clara Monzeglio, Paola Pasquino, Massimo Aglietta, Angelika C. Stern, Felice Gavosto, Flavio Carnino
Publikováno v:
Cancer. 72(10)
Administration of granulocyte-macrophage colony stimulating factor (GM-CSF) is followed by a rapid increase in the proliferative activity of the hematopoietic precursors. Within 72 hours after its suspension, however, establishment of a negative feed
Autor:
Robert Foa, A. Gillio Tos, Marco Vignetti, S. Tosti, Felice Gavosto, Giovanna Meloni, Daniela Marchis, Anna Guarini, Franco Mandelli
Publikováno v:
Recent Advances in Cell Biology of Acute Leukemia ISBN: 9783642848971
Following extensive preclinical studies both in vitro and in vivo in experimental models (Grimm et al. 1982; Lafraniere and Rosenberg 1985), the possibility of exploiting interleukin-2 (IL-2), with or without ex vivo activated lymphokine activated ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea7e9378ff8c2856979cd68c10a093b6
https://doi.org/10.1007/978-3-642-84895-7_18
https://doi.org/10.1007/978-3-642-84895-7_18
Publikováno v:
Pharmacological research. 26